Yu-Jun Dong Selected Research

Yu-Jun Dong Research Topics

Disease

5	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2020 - 12/2012
5	Lymphoma (Lymphomas) 06/2019 - 04/2002
4	Neoplasms (Cancer) 01/2023 - 04/2002
4	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 09/2012
3	Bronchiolitis Obliterans Syndrome 01/2020 - 01/2015
2	Multiple Myeloma 12/2023 - 01/2023
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2021 - 01/2020
2	Leukemia 01/2020 - 08/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2018 - 08/2016
2	Hematologic Diseases (Blood Diseases) 06/2016 - 08/2008
1	Aplastic Anemia (Anemia, Hypoplastic) 02/2024
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2023
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023
1	Amyloidosis 01/2022
1	Disease Progression 06/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2021
1	Diarrhea 10/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2020
1	Philadelphia Chromosome 02/2020
1	Vomiting 02/2020
1	Headache (Headaches) 02/2020
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2018
1	Pathologic Complete Response 04/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 04/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 08/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2016
1	Viremia 05/2012
1	Hemorrhagic Cystitis 08/2010
1	Acute Promyelocytic Leukemia 05/2010
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2010
1	Breast Neoplasms (Breast Cancer) 02/2008

Drug/Important Bio-Agent (IBA)

3	DNA (Deoxyribonucleic Acid)IBA 06/2010 - 04/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 01/2022
2	Bortezomib (Velcade)FDA Link 12/2023 - 01/2022
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 05/2012
2	thymoglobulin FDA Link 01/2020 - 08/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2018 - 04/2017
2	AntigensIBA 08/2016 - 06/2010
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2015 - 05/2012
2	HLA Antigens (Human Leukocyte Antigens)IBA 05/2012 - 08/2011
1	pomalidomideIBA 12/2023
1	Proteasome InhibitorsIBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxycycline (Periostat)FDA LinkGeneric 01/2022
1	Dasatinib (BMS 354825)FDA Link 02/2020
1	Decitabine FDA Link 02/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	Inosine Triphosphate (ITP)IBA 04/2016
1	Thrombopoietin (c-mpl Ligand)IBA 04/2016
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2013
1	ChemokinesIBA 12/2012
1	Protein Subunits (Protein Subunit)IBA 06/2010
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2010
1	Aligeron (AS 2)IBA 05/2010
1	Trastuzumab (Herceptin)FDA Link 02/2008
1	Nucleic Acid-Based VaccinesIBA 04/2002
1	RNA (Ribonucleic Acid)IBA 04/2002

Therapy/Procedure

16	Hematopoietic Stem Cell Transplantation 02/2024 - 08/2008
8	Transplantation 01/2023 - 08/2011
7	Drug Therapy (Chemotherapy) 01/2023 - 05/2010
6	Therapeutics 02/2021 - 05/2010
3	Stem Cell Transplantation 01/2023 - 02/2010
1	Radiotherapy 06/2019